🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

NHTC NHTC

Company Profile ↓
$1.61
-60.80% 1Y
Mkt Cap$20.90M
P/E-20.12
P/B0.89
52W High$4.27
52W Low$1.55
Book Value$1.81
EPS (TTM)$-0.08

Company Overview

NHTC (NHTC) is a publicly traded company listed on with a market capitalization of $20.90M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.09.

Recent Developments

  • Dec 2025 Revenue of $39.78M (-7.4% YoY); net profit $-882.00K.
  • Trailing 12 Months Year-on-year growth — revenue -7.4%, earnings -254.2%.
  • 5-Year Trend Long-term compounding — revenue CAGR 3.5%.

Growth & Price Performance

Compounded Sales Growth

5 Years:3.55%
1 Year:-7.42%

Compounded Profit Growth

5 Years:-
1 Year:-254.20%

Stock Price Performance

1 Year:-60.80%
6 Months:-54.45%
3 Months:-46.20%
1 Month:-11.54%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 2% of range
$1.55 $4.27
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)36.27 · Neutral
Price Performance
1M-11.54%
3M-46.20%
6M-54.45%
1Y-60.80%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 62.3% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-20.12
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$1.81
Price to Book
0.89
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
3.55%
Profit 5Y
-
Revenue (YoY)
-7.42%
Earnings (YoY)
-254.20%

Profitability & Returns

ROCE
-7.31%
ROE
-3.76%
ROA
-2.30%
Profit Margin
-2.22%
Op Margin
-4.55%
Gross Margin
73.54%
EPS (Latest Qtr)
$-0.05
EPS (TTM)
$-0.08

Balance Sheet & Liquidity

Debt/Equity
0.09
Quick Ratio
2.35
Current Ratio
2.50
Debt
$2.00M
Total Assets
$29.21M
Current Assets
$23.70M
Working Capital
$20.51M

Ownership

Promoter Holding
12.90%
Chg in Prom Hold
0.00%
FII / Inst Holding
12.68%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$39.78M
EBITDA
$-1.70M
Free Cash Flow
$-6.07M
Operating Cash Flow
$-6.00M
Shares Outstanding
12.98M
Gross Margin
73.54%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ------------40.13M52.37M50.91M47.04M19.33M23.43M17.02M14.95M16.40M14.12M13.47M16.15M14.28M11.55M13.36M11.72M11.86M10.51M10.62M10.95M10.47M10.69M10.74M9.81M9.48M9.75M9.21M7.60M
Cost of Revenue -----------------------------------2.56M2.49M2.64M2.30M1.88M
Gross Profit 10.81M17.91M26.68M25.08M31.78M55.62M64.78M60.07M65.33M57.05M48.63M41.67M31.95M42.15M40.51M37.12M14.10M18.02M12.65M10.43M11.59M10.49M10.21M12.22M10.61M8.64M9.97M8.62M8.83M7.84M7.93M8.04M7.78M7.93M7.91M7.25M6.99M7.11M6.90M5.72M
Operating Expenses -----------------------------------7.59M7.48M7.74M7.38M6.36M
Operating Income 1.33M3.12M6.17M5.46M6.92M12.26M14.80M13.99M14.93M15.21M12.99M12.87M8.51M10.04M10.11M7.85M-2.71M-4.00K-1.06M-1.45M183.00K668.00K220.00K385.00K479.00K-383.00K215.00K-145.00K-394.00K-743.00K-292.00K-365.00K-238.00K-275.00K-345.00K-333.00K-495.00K-635.00K-474.00K-643.00K
EBITDA ------------------------------------304.00K-467.00K-613.00K-463.00K-620.00K
Interest Expense ----------------------------------------
Pretax Income -----------------------------------15.00K-289.00K-413.00K-179.00K-453.00K
Tax Provision -----------------------------------0142.00K175.00K-25.00K-2.00K
Net Income 1.32M3.07M6.11M5.39M6.74M12.27M14.53M11.28M12.20M12.56M10.43M10.30M7.34M8.82M9.02M7.63M-1.92M397.00K-1.24M-573.00K34.00K635.00K153.00K229.00K471.00K-105.00K183.00K47.00K257.00K-219.00K172.00K188.00K173.00K35.00K122.00K15.00K-431.00K-588.00K-154.00K-451.00K
Diluted EPS 0.120.260.490.420.540.981.180.951.071.120.930.910.650.780.800.67-0.170.04-0.12-0.050.000.060.010.020.04-0.010.020.000.02-0.020.020.020.020.000.010.00-0.04-0.05-0.02-0.05

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 23.58M31.16M37.51M52.53M124.59M264.86M287.73M197.56M191.91M77.61M62.07M60.01M49.13M43.92M42.96M39.78M
Cost of Revenue ------------12.66M11.18M11.18M10.52M
Gross Profit 16.61M22.99M27.83M39.98M97.61M210.76M232.82M158.92M152.54M57.51M45.08M44.99M36.47M32.75M31.79M29.25M
Operating Expenses ------------36.74M34.42M33.08M31.06M
Operating Income -3.08M1.78M2.65M4.22M20.82M47.88M64.14M43.06M33.73M-7.02M669.00K1.57M-270.00K-1.67M-1.30M-1.81M
EBITDA -------------66.00K-1.51M-1.17M-1.70M
Interest Expense ----------------
Pretax Income ----------------
Tax Provision ------------289.00K177.00K48.00K315.00K
Net Income -2.45M2.31M2.63M4.09M20.37M47.24M55.09M23.58M31.04M-5.61M843.00K1.08M313.00K568.00K572.00K-882.00K
Diluted EPS --0.230.361.613.824.832.092.74-0.520.070.090.030.050.05-0.08

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -5.36M6.12M8.22M19.83M52.54M124.15M148.05M159.55M157.92M118.50M105.94M-82.82M69.09M55.36M38.43M
Current Assets -------------77.55M64.23M50.98M34.19M
Cash & Equivalents 1.55M648.00K1.62M4.21M14.55M44.82M104.91M125.92M135.31M132.65M96.03M92.37M-69.67M56.18M13.53M6.81M
Inventory -------------4.53M4.29M3.27M2.05M
Receivables -----------------
Total Liabilities ----13.75M26.09M67.34M65.61M68.93M68.06M43.43M38.24M-32.67M27.49M22.49M15.00M
Current Liabilities -8.18M6.93M6.31M13.75M24.43M61.51M57.15M41.92M43.08M26.30M21.51M-20.44M19.98M20.80M13.69M
Long Term Debt -----------------
Total Debt -------------4.12M3.46M2.64M2.00M
Total Equity --2.73M-809.00K1.91M6.08M26.45M56.81M82.44M90.62M89.86M75.06M67.70M-50.15M41.60M32.87M23.43M
Shares Outstanding -------------12.98M12.98M12.98M12.98M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -292.00K1.46M2.21M----26.61M29.71M-18.64M1.89M--4.85M-4.28M-3.37M-6.00M
Investing Cash Flow -3.00K-136.00K397.00K-----278.00K-214.00K-189.00K-211.00K--143.00K-46.00K-30.07M8.15M
Financing Cash Flow -58.00K-4.00K-3.00K-----17.22M-31.51M-17.46M-9.14M--9.14M-9.21M-9.21M-9.21M
Capital Expenditure -2.00K-7.00K-96.00K-210.00K-339.00K-710.00K-905.00K-278.00K-214.00K-189.00K-211.00K--143.00K-46.00K-57.00K-68.00K
Free Cash Flow -294.00K1.46M2.12M----26.33M29.50M-18.83M1.67M--5.00M-4.32M-3.42M-6.07M
Net Change in Cash -------------14.13M-13.54M-42.66M-7.06M
Share Buybacks --3.00K52.00K4.66M16.07M23.70M0010.12M0-----
Dividends Paid ----476.00K1.71M6.89M17.22M31.51M7.34M9.14M9.14M9.14M9.21M9.21M9.21M

Ratios (Annual)

Figures in %.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 70.4%73.8%74.2%76.1%78.3%79.6%80.9%80.4%79.5%74.1%72.6%75.0%74.2%74.6%74.0%73.5%
Operating Margin % -13.1%5.7%7.1%8.0%16.7%18.1%22.3%21.8%17.6%-9.0%1.1%2.6%-0.5%-3.8%-3.0%-4.5%
Net Margin % -10.4%7.4%7.0%7.8%16.3%17.8%19.1%11.9%16.2%-7.2%1.4%1.8%0.6%1.3%1.3%-2.2%
ROE % 89.7%-284.9%137.8%67.3%77.0%83.2%66.8%26.0%34.5%-7.5%1.2%-0.6%1.4%1.7%-3.8%
ROCE % 109.1%-220.4%138.6%69.5%74.1%76.4%70.6%36.6%29.4%-7.6%0.8%--0.4%-3.4%-3.8%-7.3%

Shareholding Pattern

Insiders
12.90%
Institutions
12.68%
Public Float
14.56%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NHTC

Google News Wed, 29 Jul 2026

Natural Health Trends Expects 1,000+ at Its 25th Anniversary in Hong Kong - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQNjJMcGhzY3E0eDhEc0p0RXZiNlRvQ1VFOHFwTWE2enp1emo5T0JqM3htbW5SSl9WVFpHYjY2OFVhNTZXRUx5TmtFWlJ4aXA0UU85bUlfME9tbmRjc3hTb2haMS1xZ1JKODFlZ2NzM1dxZEJTV1Q3UUgwWHJGbWcySGctNExJbVlpd3A5RV…

Google News Wed, 29 Jul 2026

Natural Health Trends Q2 revenue falls 23% to $7.6 million - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQMl9BR19ZQ1U5YTEzcnp5RDBsbU5GWVhHUUlVSGtCV3ZDV0ctTEtlOHk2TnNZWWtoaEstcUxpMF9ial8tWnlYcEhCcHZGMF95aDhmLXkxS05ZazV5a0JtS0g5dFVvZVB2VmhlR2hnSXNEeUFfbUJNbVB0cEJsTnVKYUhRTEVlc2JITHdRNF…

Google News ue, 19 May 2026

NHTC Downgraded to Underperform on Weak Demand & Cash Burn - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxONGpSVW5oUzctdzJFRHNiS0dlUHlZX3J3NThRNmp0VW5hdFNKeDNyRTZEWTdEdGdYaXlMd0ZyLUZmb1E1aUNuOTc5VWIwRnpNd0E0bDJ3N0RyM1VPNXpQMG4zbllrcjVaWkF6TlBhX1ZDWHhuN0hKR054NGhWN2FhR0t1RjdSbjMzY0JrMX…

Google News Mon, 03 Aug 2026

Natural Health Stock Slips Post Q2 Earnings, Revenues Decline Y/Y - Zacks Investment Research

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOUWxYUzN0Z2pmeDRXYzJseVFBS3lvMXdILXJXeVFMWEUxNldjanRkQWpJZXYtNkNrS3pudlV3N1lQOVZrbnFidTRBZnhUenNfMjRoUTRCcjBOMkJNa1FUN2I0Y3ZqY0RFNWk5NEdVTjBQa3BrVXN4MldndURna0NJbDctVEphWWRCTHJOWl…

Google News Mon, 27 Jul 2026

Natural Health Trends Corp. Revenue Breakdown – NASDAQ:NHTC - TradingView

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9mMFZ6akQxT2ZBc05BaVhmQVJHMHc5UEY2cnp2cVBjMVF4c3psZ0xjOUlXOGhlLW84Yk44enV6NXBneGNaVmdVRTFpUENCZkQzcUZDZnE0UmRZbjJPQkZDbkVOSVN4MWZ3V082amUzMXhtb0phMTRz?oc=5" target="_blank">Natural…

Google News hu, 15 Jan 2026

The five-year returns have been for Natural Health Trends (NASDAQ:NHTC) shareholders despite underlying losses increasing - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV2FEUFBEaFVfU1hOOWZfRXFiQy1MbHFmQTZCeEMwbUV4aXZ1eEdweEJ5alJaZ1ZET3Y5Z0FMRTJoakdYM0lVZXZDTGNxOXRiMTF1WGRGdlpEcDBzOWdsMU44WnI0U0JJYkhwa25Jb29iUjhiS0NTNWdYa1U0eFhTUU9naFR6RmplbFpkdF…

NHTC — Frequently Asked Questions

What is the current share price of NHTC?

As of 2026-08-05 17:25 PDT, NHTC trades at $1.61 on NASDAQ/NYSE. Its 52-week range is $1.55 to $4.27.

What is the market capitalisation of NHTC?

NHTC has a market capitalisation of $20.90M on NASDAQ/NYSE.

What is the P/E ratio of NHTC?

NHTC trades at a trailing price-to-earnings (P/E) ratio of -20.12. Its price-to-book (P/B) ratio is 0.89.

What is the return on equity (ROE) of NHTC?

NHTC has a return on equity (ROE) of -3.76%. Its return on capital employed (ROCE) is -7.31%.

Is NHTC a good stock to buy?

This page provides a data-driven analysis of NHTC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space